TNFRSF18 and melanoma: The melanomas with brain metastases (BM) showed higher expression of CTLA-4, and lower expression of 4-1BB, CD163, GITR, IDO1, PR, EPCAM and ER-alpha than the melanomas without metastases (Table 3, Figures 3b, e, f).